VanEck Biotech ETF
BBH
111 hedge funds and large institutions have $180M invested in VanEck Biotech ETF in 2023 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 23 increasing their positions, 36 reducing their positions, and 11 closing their positions.
85% more call options, than puts
Call options by funds: $375K | Put options by funds: $203K
12% more capital invested
Capital invested by funds: $161M → $180M (+$19.3M)
4.79% more ownership
Funds ownership: 32.83% → 37.62% (+4.8%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less funds holding
Funds holding: 115 → 111 (-4)
36% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 36
36% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIM
Miller Investment Management
West Conshohocken,
Pennsylvania
|
+$11M |
| 2 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$9.91M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$2.25M |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$1.79M |
| 5 |
JP Morgan Chase
New York
|
+$894K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.78M |
| 2 |
PGFC
Peapack-Gladstone Financial Corp
Bedminster,
New Jersey
|
-$611K |
| 3 |
Morgan Stanley
New York
|
-$517K |
| 4 |
MML Investors Services
Springfield,
Massachusetts
|
-$455K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$423K |
BBH Hedge Fund Activity: Q2 2023 in Review
111 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q2 2023, worth a combined $180M — up 12% from $161M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of BBH and 7 opened new positions — a net loss of 4 holders — while 36 trimmed existing stakes and 23 added.
The largest buyer was Miller Investment Management, adding an estimated $11M. The largest seller was Susquehanna International Group, cutting an estimated $1.78M.
- 111 institutional investors held VanEck Biotech ETF (BBH) as of Q2 2023, down from 115 in Q1 2023.
- Funds reported $180M of VanEck Biotech ETF stock for Q2 2023, up 12% quarter-over-quarter.
- 7 funds opened new VanEck Biotech ETF positions in Q2 2023 and 11 closed out, a net change of -4 holders.
- The largest VanEck Biotech ETF buyer in Q2 2023 was Miller Investment Management, an estimated $11M added.
- The largest VanEck Biotech ETF seller in Q2 2023 was Susquehanna International Group, an estimated $1.78M sold.
Based on aggregated 13F filings for Q2 2023.